| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | protein tag activity | 1.28e-05 | 14 | 67 | 3 | GO:0031386 | |
| GeneOntologyMolecularFunction | molecular tag activity | 1.28e-05 | 14 | 67 | 3 | GO:0141047 | |
| GeneOntologyMolecularFunction | glutathione transmembrane transporter activity | 2.30e-04 | 7 | 67 | 2 | GO:0034634 | |
| GeneOntologyMolecularFunction | SUMO transferase activity | 2.38e-04 | 36 | 67 | 3 | GO:0019789 | |
| GeneOntologyMolecularFunction | tripeptide transmembrane transporter activity | 3.93e-04 | 9 | 67 | 2 | GO:0042937 | |
| Domain | SUMO_chordates | 4.21e-08 | 3 | 66 | 3 | IPR027218 | |
| Domain | Sumo | 1.68e-07 | 4 | 66 | 3 | IPR033950 | |
| Domain | Rad60-SLD | 4.19e-07 | 5 | 66 | 3 | PF11976 | |
| Domain | Rad60/SUMO-like_dom | 4.19e-07 | 5 | 66 | 3 | IPR022617 | |
| Domain | UBQ | 4.70e-04 | 43 | 66 | 3 | SM00213 | |
| Domain | ubiquitin | 6.12e-04 | 47 | 66 | 3 | PF00240 | |
| Domain | UBIQUITIN_2 | 9.19e-04 | 54 | 66 | 3 | PS50053 | |
| Domain | Ubiquitin_dom | 1.13e-03 | 58 | 66 | 3 | IPR000626 | |
| Domain | FCH_dom | 2.97e-03 | 23 | 66 | 2 | IPR001060 | |
| Domain | F_BAR | 3.50e-03 | 25 | 66 | 2 | IPR031160 | |
| Domain | F_BAR | 3.50e-03 | 25 | 66 | 2 | PS51741 | |
| Domain | Ank_2 | 7.05e-03 | 215 | 66 | 4 | PF12796 | |
| Pathway | BIOCARTA_SUMO_PATHWAY | 1.20e-06 | 7 | 47 | 3 | MM1570 | |
| Pathway | REACTOME_SUMO_IS_PROTEOLYTICALLY_PROCESSED | 1.20e-06 | 7 | 47 | 3 | MM14928 | |
| Pathway | REACTOME_PROCESSING_AND_ACTIVATION_OF_SUMO | 5.63e-06 | 11 | 47 | 3 | MM14937 | |
| Pathway | REACTOME_SUMOYLATION_OF_TRANSCRIPTION_FACTORS | 1.89e-05 | 16 | 47 | 3 | MM14938 | |
| Pathway | REACTOME_SUMOYLATION_OF_INTRACELLULAR_RECEPTORS | 1.07e-04 | 28 | 47 | 3 | MM15042 | |
| Pathway | REACTOME_SUMO_IS_CONJUGATED_TO_E1_UBA2_SAE1 | 1.08e-04 | 5 | 47 | 2 | M27223 | |
| Pathway | BIOCARTA_SUMO_PATHWAY | 1.62e-04 | 6 | 47 | 2 | M22055 | |
| Pathway | REACTOME_SUMO_IS_PROTEOLYTICALLY_PROCESSED | 1.62e-04 | 6 | 47 | 2 | M27225 | |
| Pathway | REACTOME_SUMOYLATION_OF_DNA_DAMAGE_RESPONSE_AND_REPAIR_PROTEINS | 1.72e-04 | 84 | 47 | 4 | MM14929 | |
| Pathway | REACTOME_SUMO_IS_TRANSFERRED_FROM_E1_TO_E2_UBE2I_UBC9 | 2.26e-04 | 7 | 47 | 2 | M27224 | |
| Pathway | REACTOME_SUMOYLATION_OF_TRANSCRIPTION_COFACTORS | 3.15e-04 | 40 | 47 | 3 | MM15000 | |
| Pathway | REACTOME_RHOF_GTPASE_CYCLE | 3.39e-04 | 41 | 47 | 3 | MM15630 | |
| Pathway | REACTOME_RHOF_GTPASE_CYCLE | 3.64e-04 | 42 | 47 | 3 | M41821 | |
| Pathway | REACTOME_FORMATION_OF_INCISION_COMPLEX_IN_GG_NER | 4.47e-04 | 45 | 47 | 3 | MM15302 | |
| Pathway | REACTOME_PROCESSING_AND_ACTIVATION_OF_SUMO | 4.81e-04 | 10 | 47 | 2 | M27235 | |
| Pathway | REACTOME_SUMOYLATION_OF_DNA_REPLICATION_PROTEINS | 6.47e-04 | 51 | 47 | 3 | MM15151 | |
| Pathway | REACTOME_SUMOYLATION_OF_IMMUNE_RESPONSE_PROTEINS | 7.03e-04 | 12 | 47 | 2 | MM15157 | |
| Pathway | REACTOME_RHOD_GTPASE_CYCLE | 7.24e-04 | 53 | 47 | 3 | M41811 | |
| Pathway | BIOCARTA_EXTRINSIC_PATHWAY | 8.29e-04 | 13 | 47 | 2 | M4470 | |
| Pathway | BIOCARTA_EXTRINSIC_PATHWAY | 8.29e-04 | 13 | 47 | 2 | MM1395 | |
| Pathway | REACTOME_RHOD_GTPASE_CYCLE | 1.25e-03 | 64 | 47 | 3 | MM15601 | |
| Pathway | REACTOME_SUMOYLATION_OF_CHROMATIN_ORGANIZATION_PROTEINS | 1.31e-03 | 65 | 47 | 3 | MM15147 | |
| Pathway | REACTOME_RNA_POLYMERASE_II_TRANSCRIPTION_TERMINATION | 1.43e-03 | 67 | 47 | 3 | M27694 | |
| Pathway | REACTOME_SUMOYLATION_OF_TRANSCRIPTION_FACTORS | 1.99e-03 | 20 | 47 | 2 | M27237 | |
| Pathway | REACTOME_SUMOYLATION_OF_DNA_DAMAGE_RESPONSE_AND_REPAIR_PROTEINS | 2.14e-03 | 77 | 47 | 3 | M27226 | |
| Pathway | REACTOME_SUMOYLATION | 2.38e-03 | 169 | 47 | 4 | MM14919 | |
| Pathway | WP_BLOOD_CLOTTING_CASCADE | 2.41e-03 | 22 | 47 | 2 | M39480 | |
| Pathway | REACTOME_COMMON_PATHWAY_OF_FIBRIN_CLOT_FORMATION | 2.41e-03 | 22 | 47 | 2 | M17879 | |
| Pathway | REACTOME_COMMON_PATHWAY_OF_FIBRIN_CLOT_FORMATION | 2.41e-03 | 22 | 47 | 2 | MM14558 | |
| Pathway | REACTOME_PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA | 2.42e-03 | 283 | 47 | 5 | M13087 | |
| Pathway | BIOCARTA_INTRINSIC_PATHWAY | 2.63e-03 | 23 | 47 | 2 | M15997 | |
| Pathway | BIOCARTA_INTRINSIC_PATHWAY | 2.63e-03 | 23 | 47 | 2 | MM1427 | |
| Pathway | WP_BLOOD_CLOTTING_CASCADE | 2.63e-03 | 23 | 47 | 2 | MM15936 | |
| Pathway | REACTOME_GLOBAL_GENOME_NUCLEOTIDE_EXCISION_REPAIR_GG_NER | 2.65e-03 | 83 | 47 | 3 | MM15305 | |
| Pubmed | 1.26e-11 | 4 | 67 | 4 | 18708356 | ||
| Pubmed | The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers. | BLM MYL12A BPTF SRSF10 CENPC RRP1B ARID4A ATAD5 AHCTF1 NOC3L SUMO2 CCDC86 TADA3 HDGFL2 SF3B2 | 3.07e-10 | 954 | 67 | 15 | 36373674 |
| Pubmed | The in vivo Interaction Landscape of Histones H3.1 and H3.3. | BLM BPTF CENPC RRP1B ARID4A ATAD5 ZNF570 AHCTF1 SUMO3 CCDC86 HDGFL2 HOMEZ | 1.83e-09 | 608 | 67 | 12 | 36089195 |
| Pubmed | 6.83e-09 | 3 | 67 | 3 | 17077080 | ||
| Pubmed | 6.83e-09 | 3 | 67 | 3 | 20075418 | ||
| Pubmed | 6.83e-09 | 3 | 67 | 3 | 22945749 | ||
| Pubmed | SUMO2/3 conjugation is an endogenous neuroprotective mechanism. | 6.83e-09 | 3 | 67 | 3 | 21863037 | |
| Pubmed | BLM CENPC SLC25A40 RRP1B TRPM7 ATAD5 AHCTF1 NOC3L MRPS5 PGD TADA3 SNRPE HDGFL2 SF3B2 THOC5 AKAP12 | 1.64e-08 | 1487 | 67 | 16 | 33957083 | |
| Pubmed | H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids. | BLM BPTF SRSF10 RRP1B ARID4A ATAD5 AHCTF1 SUMO3 CCDC86 TADA3 SNRPE HDGFL2 SF3B2 THOC5 HOMEZ | 1.88e-08 | 1294 | 67 | 15 | 30804502 |
| Pubmed | Neuron-specific Sumo1-3 knockdown in mice impairs episodic and fear memories. | 2.73e-08 | 4 | 67 | 3 | 24690371 | |
| Pubmed | Profiles of SUMO and ubiquitin conjugation in an Alzheimer's disease model. | 2.73e-08 | 4 | 67 | 3 | 21843595 | |
| Pubmed | mRNA expression analysis of the SUMO pathway genes in the adult mouse retina. | 2.73e-08 | 4 | 67 | 3 | 25617419 | |
| Pubmed | The requirement of SUMO2/3 for SENP2 mediated extraembryonic and embryonic development. | 2.73e-08 | 4 | 67 | 3 | 31625212 | |
| Pubmed | 2.73e-08 | 4 | 67 | 3 | 20385780 | ||
| Pubmed | The SUMO2/3 specific E3 ligase ZNF451-1 regulates PML stability. | 6.81e-08 | 5 | 67 | 3 | 27343429 | |
| Pubmed | 6.81e-08 | 5 | 67 | 3 | 31749687 | ||
| Pubmed | Expression of SUMO-2/3 induced senescence through p53- and pRB-mediated pathways. | 6.81e-08 | 5 | 67 | 3 | 17012228 | |
| Pubmed | 6.81e-08 | 5 | 67 | 3 | 21632113 | ||
| Pubmed | Small ubiquitin-like modifier 2 (SUMO2) is critical for memory processes in mice. | 6.81e-08 | 5 | 67 | 3 | 32910521 | |
| Pubmed | 6.81e-08 | 5 | 67 | 3 | 29269218 | ||
| Pubmed | Sumoylation differentially regulates Sp1 to control cell differentiation. | 6.81e-08 | 5 | 67 | 3 | 24706897 | |
| Pubmed | 6.81e-08 | 5 | 67 | 3 | 25448527 | ||
| Pubmed | Characterization of mouse ubiquitin-like SMT3A and SMT3B cDNAs and gene/pseudogenes. | 6.81e-08 | 5 | 67 | 3 | 9891849 | |
| Pubmed | 6.81e-08 | 5 | 67 | 3 | 37890757 | ||
| Pubmed | 6.81e-08 | 5 | 67 | 3 | 18644859 | ||
| Pubmed | BLM MYL12A SUMO4 SRSF10 SLC25A40 RRP1B ATAD5 AHCTF1 NOC3L MRPS5 CCDC86 TADA3 SNRPE HDGFL2 RBFA | 1.26e-07 | 1497 | 67 | 15 | 31527615 | |
| Pubmed | 1.36e-07 | 6 | 67 | 3 | 24257756 | ||
| Pubmed | 1.36e-07 | 6 | 67 | 3 | 19033381 | ||
| Pubmed | Arf-induced turnover of the nucleolar nucleophosmin-associated SUMO-2/3 protease Senp3. | 1.36e-07 | 6 | 67 | 3 | 18948745 | |
| Pubmed | Mutation of SENP1/SuPr-2 reveals an essential role for desumoylation in mouse development. | 1.36e-07 | 6 | 67 | 3 | 15923632 | |
| Pubmed | 1.36e-07 | 6 | 67 | 3 | 34875212 | ||
| Pubmed | MYC multimers shield stalled replication forks from RNA polymerase. | BLM MYL12A BPTF SRSF10 CENPC RRP1B NOC3L MRPS5 SUMO2 CCDC86 SNRPE SF3B2 | 3.72e-07 | 989 | 67 | 12 | 36424410 |
| Pubmed | SUMO2 is essential while SUMO3 is dispensable for mouse embryonic development. | 3.80e-07 | 8 | 67 | 3 | 24891386 | |
| Pubmed | BLM MYL12A BPTF ARHGAP32 PYGO2 RRP1B ARID4A ATAD5 NOC3L MRPS5 SUMO2 CCDC86 TADA3 HOMEZ | 4.66e-07 | 1429 | 67 | 14 | 35140242 | |
| Pubmed | BLM BPTF CENPC ATAD5 DIAPH1 SUMO3 SUMO2 PGD TADA3 HDGFL2 SF3B2 THOC5 | 4.85e-07 | 1014 | 67 | 12 | 32416067 | |
| Pubmed | Spatiotemporal distribution of SUMOylation components during mouse brain development. | 8.12e-07 | 10 | 67 | 3 | 24639124 | |
| Pubmed | 1.12e-06 | 11 | 67 | 3 | 27009683 | ||
| Pubmed | Foxp1 regulation of neonatal vocalizations via cortical development. | 1.93e-06 | 13 | 67 | 3 | 29138280 | |
| Pubmed | 3.06e-06 | 15 | 67 | 3 | 22155005 | ||
| Pubmed | ZBTB2 protein is a new partner of the Nucleosome Remodeling and Deacetylase (NuRD) complex. | 3.47e-06 | 330 | 67 | 7 | 33301849 | |
| Pubmed | Correlation of increased hippocampal Sumo3 with spatial learning ability in old C57BL/6 mice. | 3.66e-06 | 2 | 67 | 2 | 22595540 | |
| Pubmed | Genetics of type 1 diabetes in Asian and Caucasian populations. | 3.66e-06 | 2 | 67 | 2 | 17452059 | |
| Pubmed | 3.66e-06 | 2 | 67 | 2 | 24569813 | ||
| Pubmed | 3.66e-06 | 2 | 67 | 2 | 21291420 | ||
| Pubmed | Functional heterogeneity of small ubiquitin-related protein modifiers SUMO-1 versus SUMO-2/3. | 3.66e-06 | 2 | 67 | 2 | 10692421 | |
| Pubmed | 3.66e-06 | 2 | 67 | 2 | 25262870 | ||
| Pubmed | Small ubiquitin-related modifier (SUMO) 3 and SUMO4 gene polymorphisms in Parkinson's disease. | 3.66e-06 | 2 | 67 | 2 | 32237992 | |
| Pubmed | SUMO2 and SUMO3 redundantly prevent a noncanonical type I interferon response. | 3.66e-06 | 2 | 67 | 2 | 29891701 | |
| Pubmed | The ubiquitin-proteasome system is a key component of the SUMO-2/3 cycle. | 3.66e-06 | 2 | 67 | 2 | 18565875 | |
| Pubmed | 3.66e-06 | 2 | 67 | 2 | 25047847 | ||
| Pubmed | 3.66e-06 | 2 | 67 | 2 | 22306003 | ||
| Pubmed | 3.66e-06 | 2 | 67 | 2 | 19635839 | ||
| Pubmed | SENP3-regulated Nodal signaling plays a potential role in cardiac left-right asymmetry development. | 3.76e-06 | 16 | 67 | 3 | 38925188 | |
| Pubmed | 4.56e-06 | 17 | 67 | 3 | 15767674 | ||
| Pubmed | 4.85e-06 | 660 | 67 | 9 | 32780723 | ||
| Pubmed | SUMO-specific protease 1 is essential for stabilization of HIF1alpha during hypoxia. | 5.46e-06 | 18 | 67 | 3 | 17981124 | |
| Pubmed | 6.45e-06 | 513 | 67 | 8 | 25798074 | ||
| Pubmed | HIV-1 Vpr induces cell cycle arrest and enhances viral gene expression by depleting CCDC137. | 1.02e-05 | 148 | 67 | 5 | 32538781 | |
| Pubmed | 1.03e-05 | 22 | 67 | 3 | 16524884 | ||
| Pubmed | 1.03e-05 | 22 | 67 | 3 | 27717094 | ||
| Pubmed | 1.10e-05 | 3 | 67 | 2 | 28747609 | ||
| Pubmed | 1.10e-05 | 3 | 67 | 2 | 18694876 | ||
| Pubmed | 1.10e-05 | 3 | 67 | 2 | 26223657 | ||
| Pubmed | Thrombosis Related ABO, F5, MTHFR, and FGG Gene Polymorphisms in Morbidly Obese Patients. | 1.10e-05 | 3 | 67 | 2 | 27999448 | |
| Pubmed | 1.10e-05 | 3 | 67 | 2 | 26223632 | ||
| Pubmed | 1.10e-05 | 3 | 67 | 2 | 30761470 | ||
| Pubmed | Hypoxia-induced Changes in SUMO Conjugation Affect Transcriptional Regulation Under Low Oxygen. | 1.10e-05 | 3 | 67 | 2 | 30926672 | |
| Pubmed | 1.10e-05 | 3 | 67 | 2 | 18374647 | ||
| Pubmed | 1.10e-05 | 3 | 67 | 2 | 28665748 | ||
| Pubmed | 1.10e-05 | 3 | 67 | 2 | 17164289 | ||
| Pubmed | 1.10e-05 | 3 | 67 | 2 | 32641734 | ||
| Pubmed | 1.10e-05 | 3 | 67 | 2 | 34232706 | ||
| Pubmed | 1.10e-05 | 3 | 67 | 2 | 19515723 | ||
| Pubmed | 1.10e-05 | 3 | 67 | 2 | 30403549 | ||
| Pubmed | 1.10e-05 | 3 | 67 | 2 | 24267727 | ||
| Pubmed | 1.10e-05 | 3 | 67 | 2 | 9119407 | ||
| Pubmed | 1.10e-05 | 3 | 67 | 2 | 15272016 | ||
| Pubmed | Reduced thrombin generation increases host susceptibility to group A streptococcal infection. | 1.10e-05 | 3 | 67 | 2 | 19056689 | |
| Pubmed | 1.10e-05 | 3 | 67 | 2 | 23078246 | ||
| Pubmed | Fibrinogen γ' increases the sensitivity to activated protein C in normal and factor V Leiden plasma. | 1.10e-05 | 3 | 67 | 2 | 24951429 | |
| Pubmed | 1.10e-05 | 3 | 67 | 2 | 37338025 | ||
| Pubmed | 1.10e-05 | 3 | 67 | 2 | 23077236 | ||
| Pubmed | Splenic SUMO1 controls systemic inflammation in experimental sepsis. | 1.10e-05 | 3 | 67 | 2 | 37520526 | |
| Pubmed | 1.10e-05 | 3 | 67 | 2 | 29326161 | ||
| Pubmed | NSUN2 modified by SUMO-2/3 promotes gastric cancer progression and regulates mRNA m5C methylation. | 1.10e-05 | 3 | 67 | 2 | 34504059 | |
| Pubmed | 1.10e-05 | 3 | 67 | 2 | 15456902 | ||
| Pubmed | 1.10e-05 | 3 | 67 | 2 | 26458400 | ||
| Pubmed | 1.18e-05 | 23 | 67 | 3 | 30992372 | ||
| Pubmed | A general approach for investigating enzymatic pathways and substrates for ubiquitin-like modifiers. | 1.34e-05 | 24 | 67 | 3 | 16620772 | |
| Pubmed | A bead-based approach for large-scale identification of in vitro kinase substrates. | 1.62e-05 | 163 | 67 | 5 | 22113938 | |
| Pubmed | 1.72e-05 | 26 | 67 | 3 | 7905852 | ||
| Pubmed | Mapping the Ku Interactome Using Proximity-Dependent Biotin Identification in Human Cells. | 1.81e-05 | 283 | 67 | 6 | 30585729 | |
| Pubmed | TRIM28-mediated nucleocapsid protein SUMOylation enhances SARS-CoV-2 virulence. | 1.93e-05 | 430 | 67 | 7 | 38172120 | |
| Pubmed | 1.93e-05 | 27 | 67 | 3 | 20417598 | ||
| Pubmed | Modification of DBC1 by SUMO2/3 is crucial for p53-mediated apoptosis in response to DNA damage. | 2.19e-05 | 4 | 67 | 2 | 25406032 | |
| Pubmed | 2.19e-05 | 4 | 67 | 2 | 15487983 | ||
| Pubmed | 2.19e-05 | 4 | 67 | 2 | 17428805 | ||
| Pubmed | MDM2 promotes SUMO-2/3 modification of p53 to modulate transcriptional activity. | 2.19e-05 | 4 | 67 | 2 | 21900752 | |
| Pubmed | 2.19e-05 | 4 | 67 | 2 | 12810706 | ||
| Pubmed | A basis for SUMO protease specificity provided by analysis of human Senp2 and a Senp2-SUMO complex. | 2.19e-05 | 4 | 67 | 2 | 15296745 | |
| Interaction | SMC5 interactions | BLM MYL12A BPTF SRSF10 CENPC RRP1B ARID4A ATAD5 AHCTF1 NOC3L SUMO2 CCDC86 TADA3 HDGFL2 SF3B2 | 7.49e-07 | 1000 | 67 | 15 | int:SMC5 |
| Interaction | H3C3 interactions | BLM BPTF CENPC RRP1B ARID4A ATAD5 AHCTF1 SUMO3 CCDC86 HDGFL2 | 5.16e-06 | 495 | 67 | 10 | int:H3C3 |
| Interaction | H2BC8 interactions | BLM BPTF CENPC ARID4A ATAD5 AHCTF1 UPF3B CCDC86 TADA3 HDGFL2 | 1.93e-05 | 576 | 67 | 10 | int:H2BC8 |
| Interaction | LHX2 interactions | 3.26e-05 | 183 | 67 | 6 | int:LHX2 | |
| Interaction | CENPA interactions | 3.47e-05 | 377 | 67 | 8 | int:CENPA | |
| Interaction | SNRNP40 interactions | BLM SRSF10 CENPC RRP1B ATAD5 AHCTF1 NOC3L TADA3 SNRPE HDGFL2 | 4.53e-05 | 637 | 67 | 10 | int:SNRNP40 |
| Interaction | SUMO3 interactions | 6.25e-05 | 126 | 67 | 5 | int:SUMO3 | |
| Interaction | OASL interactions | 9.76e-05 | 223 | 67 | 6 | int:OASL | |
| Interaction | ZBTB2 interactions | 1.20e-04 | 450 | 67 | 8 | int:ZBTB2 | |
| Interaction | NEK4 interactions | 1.26e-04 | 582 | 67 | 9 | int:NEK4 | |
| GeneFamily | Rho GTPase activating proteins|F-BAR domain containing | 1.35e-03 | 23 | 43 | 2 | 1288 | |
| GeneFamily | Transient receptor potential cation channels | 2.01e-03 | 28 | 43 | 2 | 249 | |
| GeneFamily | Ankyrin repeat domain containing | 2.57e-03 | 242 | 43 | 4 | 403 | |
| Coexpression | WHITFIELD_CELL_CYCLE_S | 2.38e-06 | 150 | 67 | 6 | M2075 | |
| Computational | Neighborhood of CTBP1 | 4.39e-05 | 168 | 42 | 6 | MORF_CTBP1 | |
| Computational | Neighborhood of KPNB1 | 1.80e-04 | 73 | 42 | 4 | GNF2_KPNB1 | |
| Computational | Neighborhood of AP2M1 | 1.81e-04 | 217 | 42 | 6 | MORF_AP2M1 | |
| Computational | Neighborhood of HDAC1 | 4.22e-04 | 254 | 42 | 6 | MORF_HDAC1 | |
| Disease | mean platelet volume | ARHGAP32 ARID4A SYTL4 ATAD5 CCDC62 DIAPH1 ABCC5 ARHGAP45 TRIM48 HOMEZ | 6.49e-05 | 1020 | 64 | 10 | EFO_0004584 |
| Disease | venous thromboembolism, factor VII measurement | 7.78e-05 | 38 | 64 | 3 | EFO_0004286, EFO_0004619 | |
| Disease | Colorectal Carcinoma | 1.35e-04 | 702 | 64 | 8 | C0009402 | |
| Disease | serum gamma-glutamyl transferase measurement | 1.51e-04 | 914 | 64 | 9 | EFO_0004532 | |
| Disease | Myasthenia gravis | 3.56e-04 | 13 | 64 | 2 | EFO_0004991 | |
| Disease | chemokine (C-C motif) ligand 27 measurement | 4.80e-04 | 70 | 64 | 3 | EFO_0008082 | |
| Disease | Ischemic stroke, venous thromboembolism, stroke, Abnormal thrombosis, deep vein thrombosis, pulmonary embolism | 6.17e-04 | 17 | 64 | 2 | EFO_0000712, EFO_0003827, EFO_0003907, EFO_0004286, HP_0001977, HP_0002140 | |
| Disease | late-onset myasthenia gravis | 6.93e-04 | 18 | 64 | 2 | EFO_1001490 | |
| Disease | urticaria | 8.58e-04 | 20 | 64 | 2 | EFO_0005531 | |
| Disease | prothrombin time measurement | 9.47e-04 | 21 | 64 | 2 | EFO_0008390 | |
| Disease | venous thromboembolism, plasminogen activator inhibitor 1 measurement | 9.47e-04 | 21 | 64 | 2 | EFO_0004286, EFO_0004792 | |
| Disease | venous thromboembolism, tissue plasminogen activator measurement | 1.14e-03 | 23 | 64 | 2 | EFO_0004286, EFO_0004791 | |
| Disease | partial thromboplastin time | 1.24e-03 | 24 | 64 | 2 | EFO_0004310 | |
| Disease | D dimer measurement | 1.94e-03 | 30 | 64 | 2 | EFO_0004507 | |
| Disease | factor XI measurement, venous thromboembolism | 1.94e-03 | 30 | 64 | 2 | EFO_0004286, EFO_0004694 | |
| Disease | melanoma | 2.08e-03 | 248 | 64 | 4 | C0025202 | |
| Disease | sensorineural hearing loss (is_implicated_in) | 2.34e-03 | 33 | 64 | 2 | DOID:10003 (is_implicated_in) | |
| Disease | factor VIII measurement, venous thromboembolism | 2.48e-03 | 34 | 64 | 2 | EFO_0004286, EFO_0004630 | |
| Disease | Colorectal Neoplasms | 3.10e-03 | 277 | 64 | 4 | C0009404 | |
| Disease | ascending aortic diameter | 3.53e-03 | 140 | 64 | 3 | EFO_0021787 | |
| Disease | venous thromboembolism, von Willebrand factor measurement | 3.77e-03 | 42 | 64 | 2 | EFO_0004286, EFO_0004629 | |
| Disease | liver cirrhosis (is_implicated_in) | 3.95e-03 | 43 | 64 | 2 | DOID:5082 (is_implicated_in) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| RKIMAARQKKRTPTK | 396 | O75528 | |
| KPKKRKLFRRFMSEN | 61 | A8MT66 | |
| RMKFTRISTPKKSKK | 656 | Q96QE3 | |
| KKRFSQMLQDKPLRT | 251 | Q9H6F5 | |
| GLMAKKQKRTPKRTS | 1081 | P29374 | |
| TAAMKPANLKKRKER | 271 | Q8IVF6 | |
| SIFKPSKMQRIVRLK | 536 | Q6P9F0 | |
| ASFKKMVTPKKRVRR | 611 | Q02952 | |
| TAAMKPENLKKRKKR | 271 | A2A2Z9 | |
| QSLKEMVSKLKKPRR | 56 | P52209 | |
| PSPMVKKQRRKKLTT | 826 | Q99490 | |
| KTFMPSLVVKKQRAK | 346 | Q8NAV2 | |
| RFTSMRIKKEKEKPN | 51 | O60610 | |
| RDKVKLMKFSRPKKT | 1811 | Q12830 | |
| RSSKKEASMKKVVRP | 71 | P42127 | |
| KTKKFKIPTMRVTNR | 216 | Q8IWA6 | |
| MSSKRTKTKTKKRPQ | 1 | P19105 | |
| LTTQMKKGRKRAKPR | 271 | Q8N0V3 | |
| KAMKVKTPLRALKSL | 251 | Q86VS3 | |
| FTRSKSLKILRNMKK | 746 | Q9Y2R2 | |
| FSTMKRPSREKQDKK | 346 | P02708 | |
| IFPKEFKSKKMLLRR | 486 | A5PLL1 | |
| RKTKPVLSIRMKKLT | 276 | M0R2J8 | |
| KNPRMKVKNRLFAKS | 1501 | M0R2J8 | |
| SLAMAKQKLPRKRKK | 481 | Q96PR1 | |
| KRELMKTPSISKKNR | 6 | Q92619 | |
| RLSPLMKDIKSNKFK | 931 | Q96NW7 | |
| KRAPMEKATTKKRTL | 481 | P53671 | |
| SQRPKLKRVMKEKTK | 136 | Q8IWP9 | |
| SKRKHRKIPFSKRKM | 1236 | Q9UKK3 | |
| LRTFMKSRPTKQKLK | 346 | A7KAX9 | |
| FPLERKRPQNKMKKS | 641 | A7KAX9 | |
| KRKTPALKMSVSKRA | 156 | Q7Z4V5 | |
| PRRKTAKMLKSFLKA | 271 | Q9Y251 | |
| LQMKSPEKKRRKSNT | 36 | Q9BRQ0 | |
| KLTPKMKKDKRASRG | 511 | O15440 | |
| KTTPLLSFLKNKQRM | 196 | Q9BZI7 | |
| KKTTMKIIPFNRLTI | 406 | P02679 | |
| AMKKESIQTRKRKPK | 281 | Q9BWX5 | |
| FASKTRNERKRKKMP | 1326 | P54132 | |
| EPMRKKTKFSSRNKE | 156 | Q8TD57 | |
| TIKQKQRRKFMAKPA | 416 | Q03188 | |
| NSMKKDLRLKKLPSK | 1251 | Q0VF96 | |
| MASPDRSKRKILKAK | 1 | Q5U623 | |
| RSKRKILKAKKTMPL | 6 | Q5U623 | |
| KKLSSYPKQILRRKM | 2251 | Q8WYP5 | |
| SPDMQRQRKTKRKTK | 351 | Q8IX15 | |
| MKARRNKKQIPSFRK | 1 | Q8WTT2 | |
| SAMDKERRKSLLKPK | 291 | Q8IVI9 | |
| LRFKRTHIKMKKQPK | 296 | P82675 | |
| MIFKKNTRKILRPSE | 256 | Q96C24 | |
| KTNIRLKKMASLARK | 81 | Q8IWZ4 | |
| PSQKTASLKKRKKMR | 586 | Q14684 | |
| PLELIRTKMQSKKFS | 161 | Q8TBP6 | |
| MNSSPRSKKLRLKFR | 666 | P12259 | |
| LTKARKKPSLRKDMY | 756 | P27987 | |
| RKRMFTPRKLKLTLF | 306 | Q96F83 | |
| FKIKRHTPLSKLMKA | 31 | P55854 | |
| APKLSKKKLRRMNRF | 446 | Q13435 | |
| QPKKEMKAKSRSRSA | 186 | O75494 | |
| SKKLRVGLLKMRNKS | 181 | Q8N3Z0 | |
| QFKIKRHTPLSKLMK | 31 | P61956 | |
| SKTKSRKQLGRIMLK | 66 | P62304 | |
| KRSFKKNLMAIKPKS | 196 | Q96NI8 | |
| QFKIKRQTPLSKLMK | 31 | Q6EEV6 | |
| KKMPKLRFASRIRKI | 216 | P48307 | |
| MSSESSKKRKPKVIR | 1 | Q13769 | |
| EIQMKSKKLPITRKF | 831 | Q96QT4 | |
| ELPYQSTMKRKVRKK | 21 | Q6ZT98 | |
| KPTRYQKIMKRLIKR | 776 | Q9HCX4 | |
| GPKKKKMTKARLERF | 71 | Q9HD90 |